Hi,

I am trying to compile RDKit on a RHEL7 system using Python 2.7 and Boost 1.68 
and I retrieve the following issue:
64%] Linking CXX executable testReaction
../../../lib/libRDKitChemReactions.so.1.2019.03.1dev1: undefined reference to 
`boost::archive::text_iarchive_impl<boost::archive::text_iarchive>::load_override(boost::archive::class_name_type&)'
../../../lib/libRDKitChemReactions.so.1.2019.03.1dev1: undefined reference to 
`boost::archive::archive_exception::archive_exception(boost::archive::archive_exception
 const&)'
../../../lib/libRDKitChemReactions.so.1.2019.03.1dev1: undefined reference to 
`boost::archive::text_iarchive_impl<boost::archive::text_iarchive>::load(std::__cxx11::basic_string<char,
 std::char_traits<char>, std::allocator<char> >&)'
../../../lib/libRDKitChemReactions.so.1.2019.03.1dev1: undefined reference to 
`boost::archive::text_oarchive_impl<boost::archive::text_oarchive>::save(std::__cxx11::basic_string<char,
 std::char_traits<char>, std::allocator<char> > const&)'
collect2: error: ld returned 1 exit status
make[2]: *** [Code/GraphMol/ChemReactions/testReaction] Error 1
make[1]: *** [Code/GraphMol/ChemReactions/CMakeFiles/testReaction.dir/all] 
Error 2
make: *** [all] Error 2
Has somebody already seen this error?


Best regards,
Frank

________________________________
FRANK OELLIEN, PhD
LabHead Cheminformatics and Modeling
Computer-Aided Drug Design (CADD) / Medicinal Chemistry

[cid:image001.gif@01D1640E.6AC721D0]

AbbVie Deutschland GmbH & Co KG
Neuroscience Discovery
Knollstr.
67061 Ludwigshafen
OFFICE    +49 621-589-4683
FAX          +49 621-589-63449
EMAIL     frank.oell...@abbvie.com<mailto:frank.oell...@abbvie.com>
JABBER  [cid:image001.png@01D27897.8A51B0D0] <xmpp:frank.oell...@abbvie.com> 
[cid:image002.png@01D27897.8A51B0D0] <tel:+496215894683>

abbvie.com<http://www.abbvie.com/> | Follow us:          
[cid:image008.png@01D00271.E88E8A40] <http://www.twitter.com/abbvie>  
[cid:image009.png@01D00271.E88E8A40] <http://www.facebook.com/abbviecareers>  
[cid:image011.png@01D00271.E88E8A40] 
<https://www.linkedin.com/company/1304385?trk=tyah&trkInfo=tarId%3A1403913531402%2Ctas%3AAbbVie%2Cidx%3A3-1-7>
  [cid:image013.png@01D00271.E88E8A40] <http://www.youtube.com/abbvie>
abbvie.de | Folgen Sie uns<http://www.abbvie.de/>:     
[cid:image004.png@01CDE9C9.A9800490] <https://twitter.com/abbvie_de>  
[cid:image002.png@01CDE9C9.A9800490] <https://www.facebook.com/AbbVieCareers>  
[cid:image003.png@01CDE9C9.A9800490] <https://www.linkedin.com/company/abbvie> 
[unnamed] <https://www.youtube.com/channel/UCijO89E9yhfxWkcboxrZPPw>
[cid:image012.png@01D46BC7.DBABA470]






This communication may contain information that is proprietary, confidential, 
or exempt from disclosure. If you are not the intended recipient, please note 
that any other dissemination, distribution, use or copying of this 
communication is strictly prohibited. Anyone who receives this message in error 
should notify the sender immediately by telephone or by return e-mail and 
delete it from his or her computer.
________________________________

________________________________
Sitz der Gesellschaft: Wiesbaden - Registergericht: AG Wiesbaden HRA 9790
Pers?nlich haftende Gesellschafterin: AbbVie Komplement?r GmbH
Sitz der pers?nlich haftenden Gesellschafterin: Wiesbaden - Registergericht: AG 
Wiesbaden HRB 26371
Gesch?ftsf?hrer: Dr. Patrick Horber, Thomas Scheidmeir, Dr. Stefan Simianer, 
William J. Chase
Vorsitzende des Aufsichtsrats: Dr. Azita Saleki-Gerhardt

This communication may contain information that is proprietary, confidential, 
or exempt from disclosure. If you are not the intended recipient, please note 
that any other dissemination, distribution, use or copying of this 
communication is strictly prohibited. Anyone who receives this message in error 
should notify the sender immediately by telephone or by return e-mail and 
delete it from his or her computer.

Diese Kommunikation kann Informationen enthalten, die geheim, vertraulich oder 
hinsichtlich der Offenlegung beschr?nkt sind. Wenn Sie nicht der beabsichtigte 
Empf?nger sind, nehmen Sie bitte zur Kenntnis, dass jede Weitergabe, 
Verteilung, Verwendung oder Vervielf?ltigung dieser. Kommunikation strikt 
untersagt ist. Jeder, der diese Nachricht fehlerhaft erh?lt, sollte den Sender 
unverz?glich telefonisch oder durch R?cksendung der E-Mail benachrichtigen und 
diese von seinem oder ihrem Computer l?schen.
_______________________________________________
Rdkit-discuss mailing list
Rdkit-discuss@lists.sourceforge.net
https://lists.sourceforge.net/lists/listinfo/rdkit-discuss

Reply via email to